AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliminyle-M1 Tablet PR

Diabetam-Duo tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabetam-Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, requiring adherence to a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms such as sweating, dizziness, headache, and trembling, and know how to treat them promptly. Regular meals and carrying a quick-acting glucose source (e.g., sugary snacks or juice) are crucial preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Gliminyle-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Gliminyle-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidelines. Take Gliminyle-M1 Tablet PR with meals.

Common Side effects of Gliminyle-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M1 Tablet PR:

Follow your doctor's instructions or the package directions before administering. Take Gliminyle-M1 Tablet PR with meals.

How Gliminyle-M1 Tablet PR works:

Gliminyle-M1 PR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliminyle-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliminyle-M1 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Gliminyle-M1 Tablet PR requires careful administration for individuals with impaired kidney function. Dosage modification of Gliminyle-M1 Tablet PR may be necessary. Physician consultation is recommended. Gliminyle-M1 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is prudent during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-M1 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Gliminyle-M1 Tablet PR should begin at a low dose; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Gliminyle-M1 Tablet PR :

Should you forget a dose of Gliminyle-M1 Tablet PR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gliminyle-M1 Tablet PR and seek immediate medical attention.
Gliminyle-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Gliminyle-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Gliminyle-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Gliminyle-M1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliminyle-M1 Tablet PR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Gliminyle-M1 Tablet PR
45
MRP 55
18% off